Clinical trials are the centerpiece of regulatory approval, but many sponsors still depend on fragmented workflows or legacy processes and systems that cannot keep pace with global, decentralized, and technology-enabled studies. Good Clinical Practice (GCP) requirements must be applied consistently across sites, vendors, and digital platforms. When processes are unclear or inconsistent, regulators start to question not only individual studies but the credibility of the entire development program. A strong GCP framework is more than a set of SOPs. It is an operational model that protects subjects, preserves data integrity, and can withstand inspection at any point in the trial lifecycle.
HIC helps organizations design GCP processes that work in practice, not just on paper. Our teams include former FDA investigators and experienced clinical experts who understand how trials really run under pressure. Together with your team, we map end-to-end workflows, define oversight expectations for sponsors, CROs, and vendors, and integrate risk-based quality management into daily operations. The result is a GCP framework that can support decentralized and hybrid trials, reduces regulatory risk, and keeps your organization inspection-ready throughout development.
GCP frameworks that keep trials credible
- We bring insight from former FDA inspectors who have assessed GCP across hundreds of trials and know where weaknesses are most often found
- Our experts design oversight models that explicitly account for decentralized, hybrid, and technology-enabled studies, including eCOA, eConsent, and remote monitoring
- We implement risk-based quality management that targets effort where it matters most, balancing compliance, cost, and operational reality
- Our teams align processes with ICH E6, ISO 14155, and FDA expectations so your GCP system supports global credibility and withstands detailed inspection
